Cerebrospinal
Fluid Management (CSF) Devices Market Research Report: By Product (Shunts,
Valve, External Drainage System), Age Group (Paediatric, Adult, Geriatric), End
User (Hospitals, Ambulatory Settings, and others) – Global Forecast Till 2023
Market scenario
Rising
cases of hydrocephalus is one of the key factors driving the cerebrospinal
fluid management (CSF) devices market. According to the Brain Foundation, one
in every 1,000 Australian children is born with hydrocephalus annually.
Global
cerebrospinal
fluid management (CSF) devices market size growth
is expected to grow significantly over the forecast period. It is projected to
grow at a CAGR of 4.5% over the forecast period.
Various
other factors such as rising research & development expenditure, geriatric
population, technological advancements, growing adoption of minimally invasive
procedures, and rising awareness about hydrocephalus are also expected to
propel the growth of the market.
However,
lack of trained professionals, side-effects associated with the treatment, and
high cost of devices can hinder the market growth over the forecast period.
Key players
Medtronic plc, Integra LifeSciences
Holdings Corporation, B. Braun Melsungen AG, DePuy Synthes, Spiegelberg GmbH
& Co. KG, SOPHYSA, Natus Medical Incorporated, Dispomedica GmbH, Delta
Surgical Limited, Argi Grup, Moller Medical GmbH, G. SURGIWEAR LTD., Wellong
Instruments Co., Ltd., BeckerSmith Medical, Inc., and others.
Segmentation
The Global cerebrospinal fluid management
(CSF) devices market is segmented based on product, age group, end user, and
region.
The Global market for cerebrospinal fluid
management (CSF) devices, by product is segmented into shunts, valve, and
external drainage systems.
The shunts segment is further classified
as ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP), and
ventriculopleural (VPL). The valve segment is further classified as fixed, and
adjustable. The external drainage systems segment is further classified as
external ventricular drainage (EVD) systems, and lumbar drainage (LD) systems.
Based on age group, the market is
segmented into paediatric, adult, and geriatric.
Based on end user, the market is
segmented into hospitals, ambulatory settings, clinics, research and academic
institutes, and others.
In the current scope of the study, the
above-mentioned segments are covered into the four global regions, namely the
Americas, Europe, Asia-Pacific and the Middle East & African region.
The cerebrospinal fluid management (CSF)
devices market in the Americas has further been segmented into North America
and South America, with the North American market divided into the US and
Canada.
The European cerebrospinal fluid
management (CSF) devices market has been segmented into Western Europe and Eastern
Europe. Western Europe has been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The cerebrospinal fluid management (CSF)
devices market in Asia-Pacific has been segmented into Japan, China, India,
South Korea, Australia, and the rest of Asia-Pacific. The cerebrospinal fluid
management (CSF) devices market in the Middle East & Africa has been
segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market
for cerebrospinal fluid management (CSF) devices owing to the rising geriatric
population and presence of major market players. As per the 2018 statistics
suggested by the U.S. Census Bureau, by 2035, there will be 78 million people
65 years and older compared to 76 million under the age of 18.
In 2017, it was estimated that Europe
stood second in the global cerebrospinal fluid management (CSF) devices market.
This can be attributed to the rising research and development investments and
increasing technological advancements.
Asia Pacific was projected to be the
fastest growing region in 2017. Increasing healthcare expenditure and rising
cases of hydrocephalus drives the regional markets of the Asia Pacific region.
According to the Hydrocephalus association, approximately 200,000 cases of
congenital hydrocephalus in infants are registered around the world. However,
in India, nearly 12,000 cases of congenital hydrocephalus are registered each
year.
On the other hand, the Middle East and
Africa held least cerebrospinal fluid management
(CSF) devices market share in global
market due to the low per capita income and stringent government policies,
especially within the African region.
Browse More Healthcare
Reports @
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued!
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment